If your doctor suggests phentermine first, you can ask about the comparative evidence and whether a GLP-1 might be more appropriate for sustained, long-term weight management given your specific health profile
Current MHRA and EMA licensing status should be verified via their respective websites at the time of reading
Get your custom peptide protocol: Tailored to your body and goals Precise dosing and cycle length Safe stacking combinations Backed by peer-reviewed studies Ready in under 2 minutes How AOD-9604 Works: The Mechanism Behind Before-and-After Results AOD-9604 was developed by Metabolic Pharmaceuticals in Melbourne, Australia, during the late 1990s
Summary AOD-9604 is a compact, well-studied growth hormone fragment with a narrow lipolytic mechanism, a strong safety record in toxicology studies, and a clear position in metabolic research as a GH-receptor-independent tool compound
Titration Phase After four weeks of treatment, the semaglutide dosage is increased to 0.5 mg once a week
